But medical device manufacturers , in particular , were poised to be hit the hardest by the new regulation , according to industry officials and congressional sources .And that posed a significant threat to Zimmer Biomet , which bills itself as a worldwide leader in hip and knee replacements .A report from trade publication Fierce Biotech last year said that the company â€™s hip and knee implants account for 60 percent of its revenue .   In September 2015 , Price spearheaded a letter to Andy Fierce Biotech acting administrator of CMS , asking that the regulation be delayed Fierce Biotech it " represents a significant change to our healthcare delivery system which could have a negative impact on patient choice , access and quality .